| Application no. and date | 20848921.1 (espacenet) (Federated) (European Patent Register), 20201230 | | Patent/reg. no. and date | DK/EP 4084779, 20241009 | | Publication date | 20221109 | | Priority no. and date | US 201962955062 P, 20191230, US 201962955073 P, 20191230, US 202062968695 P, 20200131, US 202062968724 P, 20200131 | | EP pub. no. and date |
EP 4084779 20221109 | | Effective date | | | Applicant/owner | Deciphera Pharmaceuticals, LLC, 200 Smith Street
Waltham, MA 02451, US | | Applicant ref. no. | | | Inventor | KAUFMAN, Michael, D., 200 Smith Street
Waltham, MA 02451, US,
BONE, Scott, 1201 NW Wall Street, Suite 200
Bend, OR 97703, US,
BLOOM, Corey, 1201 NW Wall Street, Suite 200
Bend, OR 97703, US,
JORDAN, Fred, 1201 NW Wall Street, Suite 200
Bend, OR 97703, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/4375 (2006.01) , A61K 47/38 (2006.01) , A61K 9/14 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) , A61P 35/00 (2006.01) , C07D 471/04 (2006.01) | | Title | SAMMENSÆTNINGER AF 1-(4-BROM-5-(1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-
1,6-NAPHTHYRIDIN-3-YL)-2-FLUORPHENYL)-3-PHENYLUREA | | Int. application no. | US2020067560 | | Int. publication no. | WO2021138485 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
